Reactivity-Activation of O(2) or NO in Copper and Heme-Cu Coordination Complexes
铜和血红素-Cu 配位络合物中 O(2) 或 NO 的反应活性活化
基本信息
- 批准号:10389306
- 负责人:
- 金额:$ 12.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-01 至 2026-01-31
- 项目状态:未结题
- 来源:
- 关键词:Active SitesAddressBasic ScienceBindingBiochemicalBiochemistryBiologicalCarbon DioxideCell physiologyChelating AgentsChemistryCleaved cellComplexCopperCouplingDevelopmentDiseaseEnzyme Inhibitor DrugsEnzymesEquipmentFamilyFundingGasesHealthHemeHeme IronHydrogen BondingHydroxylationInvestigationIonsLigandsLigationLyticMediatingMetalsMethane hydroxylaseMixed Function OxygenasesModelingMole the mammalMolecularNatureNitric OxideNitrogen OxidesOxidesOxidoreductaseOxygenPeroxonitritePharmaceutical PreparationsPhenolsPolysaccharidesProcessProteinsProtonsResearchRoleSpectrum AnalysisStructureTherapeuticWatercytochrome c oxidasedesignexperimental studyhyponitriteinstrumentionizationmass spectrometerpeptidylglycine alpha-amidating monooxygenasephysical propertysmall molecule
项目摘要
Project Summary/Abstract:
This equipment supplement project proposal seeks funds to purchase a Cold-Spray Ionization
Mass Spectrometer to carry out CSI-MS experiments, a powerful approach to characterizing
typically unstable reactive intermediates. The scientific objectives include the design, synthesis &
investigation of synthetic models which will aid the elucidation of fundamental aspects of structure,
M-ligation, spectroscopy and reactivity relevant to copper and heme/M (M = Cu, Fe) processing
of molecular oxygen (O2(g)) and nitric oxide (NO(g)). Copper proteins of concern include lytic
polysaccharide monooxygenases, Cu-methane monooxygenases, the enzyme family which
includes peptidylglycine monooxygenase, and a binuclear copper protein, NspF. Biochemical
research has raised questions concerning the nature of their active sites and the mechanism(s)
of action involving O2(g) activation and C-H hydroxylation. LPMOs may be peroxygenases, new
pMMO studies suggest a mono-Cu active site, and it is now questioned as to whether DBM and
PHM activate O2 with a Cu vs a Cu2 center. There are clear needs to synthesize and characterize
the copper(II)-oxyl (CuII-O·) species; it has the oxidizing ability needed for the difficult biological
substrates. We also plan to elucidate fundamentals critical to the O-O reductive cleavage process
occurring in proteins which process O2. Also, we will generate and characterize the structures,
physical properties and reactivity of new high-valent binuclear Cu(II)-O-Cu(III) complexes.
Proposed research will also focus on the heme-copper active site of cytochrome c oxidases,
where O2-binds and is reductively cleaved to give two mole-equiv water. The study of synthetic
models aids an understanding of structure, O2-binding, proton or H-bonding facilitated O-O
cleavage, and the role of the active-site phenol. Investigations are proposed to further investigate
the mechanisms of O-O cleavage in heme-peroxo-copper constructs, where the porphyrinate, the
Fe axial ligand and the copper ligand are systematically varied. A variety of planned approaches
include study of new chelates for copper which possess three N-donors and an appended phenol.
NO(g) synthetic model chemistry sub-projects with copper and heme-M will also be carried out.
With Cu complexes, the focus will be on NO(g) reductive coupling, and study of mechanisms
pertaining to the NO(g) metal-binding, formation of the N–N bond giving putative hyponitrite N2O22–
intermediates, and proton and/or H-bonding contributions to N–O cleavage and N2O formation.
Heme/Fe (or Cu) mediated NO(g) coupling is critical in NO-Reductases and synthetic models for
this process will be investigated. Metal-peroxynitrite (PN, from metal ion + O2(g) + NO(g)) reactivity,
especially toward CO2, will also be studied as relevant to biological activity.
项目摘要/摘要:
该设备补充项目提案寻求资金购买冷喷雾电离
进行CSI-MS实验的质谱仪,一种表征的强大方法
通常是不稳定的反应性中间体。科学对象包括设计,合成和
调查合成模型,这些模型将有助于阐明结构的基本方面,
与铜和血红素/M(M = Cu,Fe)加工有关的M结合,光谱和反应性
分子氧(O2(G))和一氧化氮(NO(G))的含量。关注的铜蛋白包括裂解
多糖单加氧酶,Cu-甲烷单加氧酶,酶家族,该酶家族
包括肽基甘氨酸单加氧酶和均质铜蛋白NSPF。生化
研究提出了有关其主动地点的性质和机制的问题
涉及O2(G)激活和C-H羟基化的作用。 lpmos可能是过氧化物酶,新的
PMMO研究建议一个单一的活动部位,现在质疑DBM和是否是否
PHM用Cu与Cu2中心激活O2。明确需要合成和表征
铜(II)-Oxyl(CuII-O·)物种;它具有困难的生物学所需的氧化能力
基材。我们还计划阐明对O-O减少裂解过程至关重要的基础知识
发生在O2过程的蛋白质中。另外,我们将生成和表征结构,
新高价值双核Cu(II)-O-Cu(III)配合物的物理特性和反应性。
拟议的研究还将集中于细胞色素C氧化酶的血红素活性部位,即
o2结合并减少裂解以得到两个摩尔含量水。合成研究
模型有助于了解制备的O-O的结构,O2结合,质子或H键键
裂解和活性位点酚的作用。提出了调查以进一步调查
O-O裂解在血红素 - 过氧 - 波普构建体中的机理,卟啉酸酯,
Fe轴向配体和铜配体有系统的变化。各种计划的方法
包括研究新樱桃的铜的研究,该铜拥有三个N donors和一个附加的苯酚。
也将进行无铜和血红素M的NO(G)合成模型化学对象。
使用CU复合物,重点将放在NO(G)减少的耦合上,并研究机制
与NO(G)金属结合有关
中间体以及质子和/或H键对N – O裂解和N2O形成的贡献。
血红素/Fe(或Cu)介导的NO(G)耦合在NO-REDUCTass和合成模型中至关重要
该过程将进行调查。金属 - 过氧亚硝酸盐(PN,来自金属离子 + O2(g) + NO(G))反应性,
尤其是针对二氧化碳,还将研究与生物活性有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH D. KARLIN其他文献
KENNETH D. KARLIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH D. KARLIN', 18)}}的其他基金
Reactivity-Activation of O(2) or NO in Copper and Heme-Cu Coordination Complexes
铜和血红素-Cu 配位络合物中 O(2) 或 NO 的反应活性活化
- 批准号:
10322111 - 财政年份:2021
- 资助金额:
$ 12.48万 - 项目类别:
Reactivity-Activation of O(2) or NO in Copper and Heme-Cu Coordination Complexes
铜和血红素-Cu 配位络合物中 O(2) 或 NO 的反应活性活化
- 批准号:
10551343 - 财政年份:2021
- 资助金额:
$ 12.48万 - 项目类别:
HEME/COPPER AND HEME/NONHEME IRON O2 AND NO REACTIVITY
血红素/铜和血红素/非血红素铁 O2,无反应性
- 批准号:
6031285 - 财政年份:2000
- 资助金额:
$ 12.48万 - 项目类别:
HEME/COPPER AND HEME/NONHEME IRON O2 AND NO REACTIVITY
血红素/铜和血红素/非血红素铁 O2,无反应性
- 批准号:
6520128 - 财政年份:2000
- 资助金额:
$ 12.48万 - 项目类别:
Heme/Copper and Heme/Nonheme Iron O(2) and NO Reactivity
血红素/铜和血红素/非血红素铁 O(2) 和 NO 反应性
- 批准号:
7934676 - 财政年份:2000
- 资助金额:
$ 12.48万 - 项目类别:
Heme/Copper and Heme/Non-Heme Iron O2 and NO Reactivity
血红素/铜和血红素/非血红素铁 O2 和 NO 反应性
- 批准号:
7218067 - 财政年份:2000
- 资助金额:
$ 12.48万 - 项目类别:
HEME/COPPER AND HEME/NONHEME IRON O2 AND NO REACTIVITY
血红素/铜和血红素/非血红素铁 O2,无反应性
- 批准号:
6387045 - 财政年份:2000
- 资助金额:
$ 12.48万 - 项目类别:
Heme/Copper and Heme/Nonheme Iron O(2) and NO Reactivity
血红素/铜和血红素/非血红素铁 O(2) 和 NO 反应性
- 批准号:
9980910 - 财政年份:2000
- 资助金额:
$ 12.48万 - 项目类别:
Heme/Copper and Heme/Nonheme Iron O(2) and NO Reactivity
血红素/铜和血红素/非血红素铁 O(2) 和 NO 反应性
- 批准号:
7730922 - 财政年份:2000
- 资助金额:
$ 12.48万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Leveraging Adaptive Evolution and High-Throughput Techniques to Dissect the Link Between Biochemical Function and Fitness
利用适应性进化和高通量技术来剖析生化功能与健康之间的联系
- 批准号:
10704076 - 财政年份:2022
- 资助金额:
$ 12.48万 - 项目类别:
Leveraging Adaptive Evolution and High-Throughput Techniques to Dissect the Link Between Biochemical Function and Fitness
利用适应性进化和高通量技术来剖析生化功能与健康之间的联系
- 批准号:
10480295 - 财政年份:2022
- 资助金额:
$ 12.48万 - 项目类别:
Development of small molecule inhibitors of metabolic enzymes as broad spectrum anthelmintic drugs
开发小分子代谢酶抑制剂作为广谱驱虫药
- 批准号:
10370382 - 财政年份:2021
- 资助金额:
$ 12.48万 - 项目类别:
Reactivity-Activation of O(2) or NO in Copper and Heme-Cu Coordination Complexes
铜和血红素-Cu 配位络合物中 O(2) 或 NO 的反应活性活化
- 批准号:
10322111 - 财政年份:2021
- 资助金额:
$ 12.48万 - 项目类别:
Development of small molecule inhibitors of metabolic enzymes as broad spectrum anthelmintic drugs
开发小分子代谢酶抑制剂作为广谱驱虫药
- 批准号:
10581534 - 财政年份:2021
- 资助金额:
$ 12.48万 - 项目类别: